Jennifer Jarrett, Chief Operating Officer at Arcus Biosciences, Inc. (RCUS), sold 45,000 shares at $20.25 ($911K) on 2023-07-28, disclosed to the SEC on 2023-07-31.
Scheduled sale ($911k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RCUS | SELL | 2025-10-08 | $1.3M | — | Filing → |
| RCUS | SELL | 2024-03-29 | $405K | — | Filing → |
| RCUS | SELL | 2024-03-20 | $458K | — | Filing → |